Abadi SSH,Gangadharappa H,Balamuralidhara VJ H .2020 .Development of colon-specific mucoadhesive meloxicam microspheres for the treatment of CFAinduced arthritis in rats. Int. J. Polyme. Mate. Polyme. Biomater, 70(12) : 849-869.
Avdeef ,Development Drug .2012 .Permeability PAMPA. , : 319-498.
Bae JW,Kim MJ,Jang CG,Lee SYJJOCB .2007 .Determination of meloxicam in human plasma using a HPLC method with UV detection and its application to a pharmacokinetic study. J. Chromatograp. B, 859(1) : 69-73.
Chaudhari VS,Borkar RM,Murty US,Banerjee S US .2020 .Analytical method development and validation of reverse-phase high-performance liquid chromatography (RP-HPLC) method for simultaneous quantifications of quercetin and piperine in dual-drug loaded nanostructured lipid carriers. J. Pharmaceu. Biomed Analy, 186 : 113325.
Chen YC,Moseson DE,Richard CA,Swinney MR,Horava SD,Oucherif KA,Cox AL,Hawkins ED,Li Y .2022 .Development of hot-melt extruded drug/polymer matrices for sustained delivery of meloxicam. J. Controlled Release, 342 : 189-200.
Hombreiro-Perez M,Siepmann J,Zinutti C,Lamprecht A,Ubrich N,Hoffman M,Bodmeier R,Maincent P .2003 .Non-degradable microparticles containing a hydrophilic and/or a lipophilic drug: preparation, characterization and drug release modeling. J. Controlled Release, 88 : 413-428.
Jafari H,Mahdavinia GR,Kazemi B,Ehrlich H,Joseph Y,Rahimi-Nasrabadi M .2021 .Highly efficient sunitinib release from pH-responsive mHPMC@ Chitosan core-shell nanoparticles. J. Carbohydrate Polymers, 258 : 117719.
Jiang Q,Wang J,Ma P,Liu C,Sun M,Sun Y,He Z Y .2018 .Ion-pair formation combined with a penetration enhancer as a dual strategy to improve the transdermal delivery of meloxicam. J. Drug Deliv. Trans. Res., 8(1) : 64-72.
Kashif PM,Madni A,Ashfaq M,Rehman M,Mahmood MA,Khan MI,Tahir N MI .2017 .Development of Eudragit RS 100 microparticles loaded with ropinirole: optimization and in vitro evaluation studies. J. AAPS Pharmscitech, 18(5) : 1810-1822.
Katona G,Balogh GT,Dargo G,Gáspár R,Márki Á,Ducza E,Sztojkov-Ivanov A,Tomosi F,Kecskeméti G,Janáky T .2020 .Development of meloxicamhuman serum albumin nanoparticles for nose-to-brain delivery via application of a quality by design approach. J. Pharmaceutics, 12(2) : 97.
Khan KU,Minhas MU,Sohail M,Badshah SF,Abdullah O,Khan S,Munir A,Suhail M .2021 .Synthesis of PEG-4000-co-poly (AMPS) nanogels by cross-linking polymerization as highly responsive networks for enhancement in meloxicam solubility. J. Drug Devel. Indust. Pharma, 47(3) : 465-476.
Krier F,Brion M,Debrus B,Lebrun P,Driesen A,Ziemons E,Evrard B,Hubert P .2011 .Optimisation and validation of a fast HPLC method for the quantification of sulindac and its related impurities. J. Pharmaceut. Biomed Analy, 54(4) : 694-700.
Maqbool I,Akhtar M,Ahmad R,Sadaquat H,Noreen S,Batool A,Khan SU .2020 .Novel multiparticulate pH triggered delayed release chronotherapeutic drug delivery of celecoxib-β-cyclodextrin inclusion complexes by using Box-Behnken design. Eue. J. Pharm. Sci., 146 : 105254.
Montejo C,Barcia E,Negro S,Fernández-Carballido A .2010 .Effective antiproliferative effect of meloxicam on prostate cancer cells: Development of a new controlled release system. Int. J. Pharmaceutics, 387(1-2) : 223-229.
Patel MM .2017 .Formulation and development of didependent microparticulate system for colon-specific drug delivery. J. Drug Deliv. Trans. Res, 7(2) : 312-324.
Q8 I .2005 .ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use. Topic Q9: Quality Risk Management Geneva. , : .
Rashid M,Kaur V,Hallan SS,Sharma S,Mishra N S .2016 .Microparticles as controlled drug delivery carrier for the treatment of ulcerative colitis: A brief review. Saudi, 24(4) : 458-472.
Fitzgerald Ricciotti E,GA Ricciotti E .2011 .Prostaglandins and inflammation. J. Arteriosclerosis, Thrombo. Vascular Biol, 31(5) : 986-1000.
Sharma M,Kohli S,Dinda A .2015 .In-vitro and invivo evaluation of repaglinide loaded floating microspheres prepared from different viscosity grades of HPMC polymer. Saudi Pharm. J., 23(6) : 675-682.
Sheikh FA,Aamir MN,Haseeb MT,Bukhari SNA,Ul Haq MF,Akhtar N MF .2021 .Design, physicochemical assessment and pharmacokinetics of a nontoxic orodispersible film for potential application in musculo-skeletal disorder. J. Drug Deliv. Sci. Tech, 65 : 102726.
Shi Y,Liu Z,Yang Y,Xu X,Li Y,Li T Y .2017 .Design of poly (mPEGMA-co-MAA) hydrogel-based mPEGb-PCL nanoparticles for oral meloxicam delivery. J. Matr. Sci. Eng, 76(1) : 975-984.
Suzuki R,Yamamoto M,Saka H,Taniguchi H,Shindoh J,Tanikawa Y,Nomura F,Gonda H,Imaizumi K,Hasegawa Y .2009 .A phase II study of carboplatin and paclitacel with meloxicam. J. Lung Cancer, 63(1) : 72-76.
Wasay SA,Jan SU,Akhtar M,Noreen S,Gul R .2022 .Developed meloxicam loaded microparticles for colon targeted delivery: Statistical optimization, physicochemical characterization and in-vivo toxicity study. PLoS ONE, 17(4) : e0267306.